awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48507354-33B46717-41E8-4107-B244-D53E983D38C4
Q48507354-33B46717-41E8-4107-B244-D53E983D38C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48507354-33B46717-41E8-4107-B244-D53E983D38C4
Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors.
P2860
Q48507354-33B46717-41E8-4107-B244-D53E983D38C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48507354-33B46717-41E8-4107-B244-D53E983D38C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
72d41444001f1e11de3763d162e168fec167e675
P2860
Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer.